CLLS
HEALTHCARECellectis
$3.95+0.19 (+5.05%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving CLLS Today?
No stock-specific AI insight has been generated for CLLS yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.33$5.48
$3.95
Fundamentals
Market Cap$397M
P/E Ratio—
EPS$-0.67
Dividend Yield—
Dividend / Share—
ROE-0.7%
Profit Margin-0.8%
Debt / Equity—
Trading
Volume18K
Avg Volume (10D)—
Shares Outstanding72.6M
CLLS News
20 articles- Monthly information on share capital and company voting rightsYahoo Finance·May 6, 2026
- European Equities Traded in the US as American Depositary Receipts Climb Sharply Higher in Wednesday TradingYahoo Finance·May 6, 2026
- Cellectis to Report First Quarter Financial Results on May 11, 2026Yahoo Finance·May 4, 2026
- European Equities Traded in the US as American Depositary Receipts Start Week LowerYahoo Finance·May 4, 2026
- European Penny Stocks To Watch In May 2026Yahoo Finance·May 4, 2026
- European Equities Traded in the US as American Depositary Receipts Flat in Friday Trading; Gain 1.3% for WeekYahoo Finance·May 1, 2026
- European Equities Traded in the US as American Depositary Receipts Lower in Wednesday TradingYahoo Finance·Apr 29, 2026
- Cellectis Presents Epigenetic Editing Platform to Turn Genes Off Without Altering DNA at the ASGCT Annual MeetingYahoo Finance·Apr 27, 2026
- European Equities Traded in the US as American Depositary Receipts Rise in Friday TradingYahoo Finance·Apr 24, 2026
- European Equities Traded in the US as American Depositary Receipts Declining in Thursday TradingYahoo Finance·Apr 16, 2026
- Cema-Cel Pivotal Trial Interim Data Highlight Strength of Cellectis’ Allogeneic CAR-T PlatformYahoo Finance·Apr 13, 2026
- European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday TradingYahoo Finance·Apr 13, 2026
- European Equities Traded in the US as American Depositary Receipts Decline in Thursday TradingYahoo Finance·Apr 9, 2026
- European Equities Traded in the US as American Depositary Receipts Track Lower in Tuesday TradingYahoo Finance·Apr 7, 2026
- European Equities Traded in the US as American Depositary Receipts Decline in Monday TradingYahoo Finance·Apr 6, 2026
- European Equities Traded in the US as American Depositary Receipts Rising Sharply in Wednesday TradingYahoo Finance·Apr 1, 2026
- European Equities Traded in the US as American Depositary Receipts Rise in Tuesday TradingYahoo Finance·Mar 31, 2026
- European Equities Traded in the US as American Depositary Receipts Rise in Monday TradingYahoo Finance·Mar 30, 2026
- Cellectis SA (CLLS) Q4 2025 Earnings Call Highlights: Promising Clinical Progress and Strategic ...Yahoo Finance·Mar 20, 2026
- European Equities Traded in the US as American Depositary Receipts Fall in Friday Trading; Drop Over 2% for WeekYahoo Finance·Mar 20, 2026
All 20 articles loaded
Price Data
Open$3.94
Previous Close$3.76
Day High$3.94
Day Low$3.86
52 Week High$5.48
52 Week Low$1.33
52-Week Range
$1.33$5.48
$3.95
Fundamentals
Market Cap$397M
P/E Ratio—
EPS$-0.67
Dividend Yield—
Dividend / Share—
ROE-0.7%
Profit Margin-0.8%
Debt / Equity—
Trading
Volume18K
Avg Volume (10D)—
Shares Outstanding72.6M
About Cellectis
Cellectis SA, a clinical-stage biotechnology company, develops immuno-oncology products based on gene-edited T cells that express chimeric antigen receptors to attack and eradicate cancer cells. The company is headquartered in Paris, France.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—